Extended Disease-Free Interval of 6 Years in a Recurrent Glioblastoma Multiforme Patient Treated With G207 Oncolytic Viral Therapy

Oncolytic Virotherapy
doi 10.2147/ov.s62461
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Glioblastoma Multiforme in a Patient With Isolated Hemimegalencephaly

Journal of Neurological Surgery Reports
2015English

Treatment of Recurrent Glioblastoma Multiforme (rGBM) With Antineoplaston AS2-1 in Combination With Targeted Therapy

Cancer and Clinical Oncology
2019English

Pregnancy in a Patient With Recurrent Glioblastoma

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2013English

Oncolytic Myxoma Virus Synergizes With Standard of Care for Treatment of Glioblastoma Multiforme

Oncolytic Virotherapy
2018English

Radiosurgery for Recurrent Glioblastoma Multiforme: A Single Institution Experience

Canadian Journal of Neurological Sciences
MedicineNeurology
2014English

Development of an Integrated Monte Carlo Model for Glioblastoma Multiforme Treated With Boron Neutron Capture Therapy

Scientific Reports
Multidisciplinary
2017English

Oncolytic Viral Therapy of Malignant Glioma

Neurotherapeutics
NeurologyPharmacology
2009English

Comprehensive Portrait of Recurrent Glioblastoma Multiforme in Molecular and Clinical Characteristics

Oncotarget
Oncology
2015English

High-Dose BCNU With Autologous Bone Marrow Rescue for Recurrent Glioblastoma Multiforme

Journal of Neurosurgery
SurgeryNeurology
1981English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy